Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What Growth Rate is Forecasted for the Neurological Biomarkers Market over the 2024-2033 Period?

In recent years, the size of the neurological biomarkers market has experienced significant growth. It is projected to rise from $9.46 billion in 2023 to $10.63 billion in 2024, demonstrating a compound annual growth rate (CAGR) of 12.4%. The past growth can be related to factors including the rising occurrence of neurological disorders, an aging population, the demand for drug development, heightened funds for neurological research, and the advent of personalized medicine.

In the coming years, the neurological biomarkers market is projected to witness quick expansion. It’s estimated that this market will increase to $17.18 billion by 2028, with a compound annual growth rate (CAGR) of 12.7%. Multiple factors contributing to this expected growth include the use of biomarkers for early detection, the application of biosensors, the ubiquity of wearable devices, worldwide health initiatives, and a patient-centric approach. Key trends during the predicted period comprise technological innovation in imaging, swift progress in omics technologies, the incorporation of artificial intelligence (AI), application of real-world evidence in biomarker validation, advancements in diagnostic technologies, and industry-research institution collaborations.

Claim Your Free Sample of the Global Neurological Biomarkers Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12677&type=smp

Which Factors Are Stimulating Growth in the neurological biomarkers Market?

The rising incidence of neurological disorders is projected to stimulate the expansion of the neurological biomarker industry. These disorders impact the brain, spinal cord, and the other nerves in the body. One such neurodegenerative disease is Parkinson’s, which affects the neurological system along with body parts under nerve control. Neurological biomarkers utilize pathological, biochemical, and genetic examination to detect Parkinson’s disease at an early stage. For instance, the Parkinson’s Foundation, a non-profit organization based in the US, reported in December 2022 that new diagnoses of Parkinson’s disease had surged to 90,000 that year, a significant increase from 60,000 yearly diagnoses in 2021. Therefore, the escalating prevalence of neurological conditions is fueling the expansion of the neurological biomarker industry.

What Are the Main Segments of the Neurological Biomarkers Market?

1) By Product: Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products

2) By Application: Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy

3) By End-User: Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Other End-Users

What Innovative Trends Are Redefining the Neurological Biomarkers Landscape?

In an attempt to fortify their market positions and expedite the invention of new products, major entities within the neurological biomarkers market are cultivating partnerships. Cooperation in this market serves to inspire innovation, tap into varying forms of expertise and speed up the development and market introduction of cutting-edge therapies using a collaborative approach. For instance, in July 2022, NeuroSense Therapeutics Ltd., a leading company from Israel in the field of neurodegenerative disease treatments, joined hands with NeuraLight, another Israeli company dedicated to developing targeted biomarkers for neurological ailments. The aim was to pinpoint oculometric indicators for Amyotrophic Lateral Sclerosis (ALS) with the assistance of Artificial Intelligence (AI) and Machine Learning (ML). The alliance, which was formed on the heels of NeuraLight’s $25 million Series A financing round, intends to amplify the identification and utilization of digital ALS indicators in a simultaneous study, marking the initial clinical trial of this collaboration. The joint venture revolves around the use of oculometric digital indicators, potentially enabling patient categorization and enhancing the success rate of clinical trials.

Order Now for Fast Delivery of Your Neurological Biomarkers Market Report!

https://www.thebusinessresearchcompany.com/report/neurological-biomarkers-global-market-report

Which Regions Are Key Players in the Growth of the Neurological Biomarkers Market?

North America was the largest region in the neurological biomarkers market in 2023. The regions covered in the neurological biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Neurological Biomarkers Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the neurological biomarkers market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Neurological Biomarkers Market Include

1. Neurological Biomarkers Market Executive Summary

2. Neurological Biomarkers Market Segments

3. Neurological Biomarkers Market Size And Template Market Growth Rate

4. Key Neurological Biomarkers Market Trends

5. Major Neurological Biomarkers Market Drivers

……

25. Key Mergers And Acquisitions In The Neurological Biomarkers Market

26. Top Neurological Biomarkers Companies

27. Neurological Biomarkers Market Opportunities And Strategies

28. Neurological Biomarkers Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Biomarkers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Renal Biomarkers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

Cardiac Biomarkers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: